• Parker Institute for Cancer Immunotherapy appoints chief scientific officer

    11 monthes ago - By Healio

    Parker Institute for Cancer Immunotherapy appointed John Connolly, PhD, as its chief scientific officer.
    Parker will work with the institute's leadership team, center directors and scientific steering team to design and execute its overall research strategy. He also will identify and expand partnerships with biotechnology and pharmaceutical companies to support the institute's research efforts.
    “As looks to the future, it is critical that we identify and target the most promising areas of cancer immunotherapy and collaborate with the right industry partners to
    Read more ...